Instil Bio Inc
TIL
Market Cap$73.04M
Close$
$11.77
1% downside
Current Fair Value
1% downsideOvervalued by 1% based on the discounted cash flow analysis.
Share Statistics
| Market cap | $73.04 Million |
|---|---|
| Enterprise Value | - |
| Dividend Yield | $0.0 (0.0%) |
| Earnings per Share | $0.0 |
| Beta | 0.36 |
| Outstanding Shares | 6,503,913 |
| Avg 30 Day Volume | 10,958 |
Return
| Return on Equity | - |
|---|---|
| Return on Assets | - |
| Return on Invested Capital | - |
Valuation & Multiples
| P/E Ratio | 0.0 |
|---|---|
| PEG | - |
| Price to Sales | - |
| Price to Book Ratio | - |
| Enterprise Value to Revenue | - |
| Enterprise Value to EBIT | - |
| Enterprise Value to Net Income | - |
| Total Debt to Enterprise | - |
| Debt to Equity | - |
Revenue Sources
No data
ESG Score
No data
About Instil Bio Inc
150 employeesInstil Bio, Inc. is a clinical-stage biopharmaceutical company focused on developing an innovative cell therapy pipeline of autologous TIL therapies for the treatment of patients with cancer.